aureus. Fortunately, a number of new agents active against MRSA and other Gram-positive pathogens have been developed and introduced into the clinics. Linezolid, daptomycin and tigecycline are ...
Innoviva (INVA) announced it has entered into an exclusive distribution and license agreement with Basilea Pharmaceutica for the commercialization of Zevtera, an advanced-generation cephalosporin ...
Examples such as Methicillin-resistant Staphylococcus aureus (MRSA) highlight the danger of resistance. Once easily treatable, infections like MRSA now require last-resort drugs, which are often ...